Table 1.
Chemical modification | Advantage | Disadvantage | References |
---|---|---|---|
3′-inverted dT | Improved stability Does not disrupt catalytic function Can improve cleavage |
Relatively short half-life | [1,40–43] |
Phosphorothioate (PS) | Improved stability Increases cellular uptake |
Decrease substrate affinity Toxic side effects |
[1,36,42,44–49] |
2′-O-methyl (2′-O-Me) | Improved stability Can be incorporated into core |
Reduced cleavage ability | [37,38] |
Locked nucleic acid (LNA) | Improved base pairing selectivity and efficiency Reduced sequence length Improved stability Improves binding to highly structured RNAs |
Inflexible/rigid structure Reduced cleavage ability Reduced multiple turnover |
[1,37,50–52] |
2′-O-(N-(aminoethyl)carbamoyl) methyl | Improved catalytic function | [53–56] | |
2′-deoxyadenosine analogues | Improved catalytic function | [57] | |
2′deoxyuridine derivative containing a guanidinium group | Reduced negative charge (increased cellular uptake) | May reduce catalytic ability | [58] |
Phosphorodiamidate morpholino oligonucleotides (PMO) | Improved stability Excellent safety profile |
Has not been applied to DNAzymes May lower catalytic ability Reduced binding affinity |
[59] |
2′-fluoroarabino nucleic acid (FANA) and α-l-threofuranosyl nucleic acid backbone (XNA) | Improved catalytic function Improved stability Allele specificity |
[60,61] |